MarketScreener Editorial Features Frazier Lifesciences Acquisition Corporation
Equities
NAMS
NL00150012L7
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.21 EUR | -5.69% | -8.96% | +80.93% |
May. 09 | Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M | MT |
May. 08 | NewAmsterdam Pharma Company N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- NAMS Stock
- News Frazier Lifesciences Acquisition Corporation
- MarketScreener Editorial Features